• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体靶向基因传递的最新进展。

Recent Advances in Mitochondria-Targeted Gene Delivery.

机构信息

Department of Chemical and Biological Engineering, Sookmyung Women's University, Seoul 04310, Korea.

Institute of Advanced Materials and Systems, Sookmyung Women's University, Seoul 04310, Korea.

出版信息

Molecules. 2018 Sep 11;23(9):2316. doi: 10.3390/molecules23092316.

DOI:10.3390/molecules23092316
PMID:30208599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6225103/
Abstract

Mitochondria are the energy-producing organelles of cells. Mitochondrial dysfunctions link to various syndromes and diseases including myoclonic epilepsy and ragged-red fiber disease (MERRF), Leigh syndrome (LS), and Leber hereditary optic neuropathy (LHON). Primary mitochondrial diseases often result from mutations of mitochondrial genomes and nuclear genes that encode the mitochondrial components. However, complete intracellular correction of the mutated genetic parts relevant to mitochondrial structures and functions is technically challenging. Instead, there have been diverse attempts to provide corrected genetic materials with cells. In this review, we discuss recent novel physical, chemical and biological strategies, and methods to introduce genetic cargos into mitochondria of eukaryotic cells. Effective mitochondria-targeting gene delivery systems can reverse multiple mitochondrial disorders by enabling cells to produce functional mitochondrial components.

摘要

线粒体是细胞的能量产生细胞器。线粒体功能障碍与多种综合征和疾病有关,包括肌阵挛性癫痫伴破碎红纤维病(MERRF)、 Leigh 综合征(LS)和 Leber 遗传性视神经病变(LHON)。原发性线粒体疾病通常是由线粒体基因组和编码线粒体成分的核基因突变引起的。然而,完全纠正与线粒体结构和功能相关的突变遗传部分在技术上具有挑战性。相反,人们已经尝试了多种方法来为细胞提供纠正后的遗传物质。在这篇综述中,我们讨论了最近用于将遗传物质递送到真核细胞线粒体的新型物理、化学和生物学策略及方法。有效的靶向线粒体的基因传递系统可以通过使细胞产生功能性线粒体成分来逆转多种线粒体疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8219/6225103/8d2bf07b7733/molecules-23-02316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8219/6225103/9fb59ded03b0/molecules-23-02316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8219/6225103/8d2bf07b7733/molecules-23-02316-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8219/6225103/9fb59ded03b0/molecules-23-02316-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8219/6225103/8d2bf07b7733/molecules-23-02316-g002.jpg

相似文献

1
Recent Advances in Mitochondria-Targeted Gene Delivery.线粒体靶向基因传递的最新进展。
Molecules. 2018 Sep 11;23(9):2316. doi: 10.3390/molecules23092316.
2
Pathogenic Mitochondria DNA Mutations: Current Detection Tools and Interventions.致病性线粒体 DNA 突变:当前的检测工具和干预措施。
Genes (Basel). 2020 Feb 12;11(2):192. doi: 10.3390/genes11020192.
3
Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.视神经病变中的新兴线粒体治疗靶点。
Pharmacol Ther. 2016 Sep;165:132-52. doi: 10.1016/j.pharmthera.2016.06.004. Epub 2016 Jun 8.
4
Gene therapy for mitochondrial diseases: Leber Hereditary Optic Neuropathy as the first candidate for a clinical trial.线粒体疾病的基因治疗:Leber遗传性视神经病变作为临床试验的首个候选对象。
C R Biol. 2014 Mar;337(3):193-206. doi: 10.1016/j.crvi.2013.11.011. Epub 2014 Feb 24.
5
Mitochondrial biogenesis: pharmacological approaches.线粒体生物合成:药理学方法。
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
6
Detection of heteroplasmic mitochondrial DNA in single mitochondria.检测单个线粒体中的异质体线粒体 DNA。
PLoS One. 2010 Dec 16;5(12):e14359. doi: 10.1371/journal.pone.0014359.
7
Leber Hereditary Optic Neuropathy: Bringing the Lab to the Clinic.Leber遗传性视神经病变:从实验室到临床应用
Semin Ophthalmol. 2016;31(1-2):107-16. doi: 10.3109/08820538.2015.1115251.
8
[MITO-Porter; a cutting-edge technology for mitochondrial gene therapy].[线粒体载体;一种用于线粒体基因治疗的前沿技术]
Yakugaku Zasshi. 2012;132(12):1389-98. doi: 10.1248/yakushi.12-00235-3.
9
Movement disorders in mitochondrial diseases.线粒体疾病中的运动障碍。
Rev Neurol (Paris). 2016 Aug-Sep;172(8-9):524-529. doi: 10.1016/j.neurol.2016.07.003. Epub 2016 Jul 28.
10
Emerging therapies for mitochondrial diseases.线粒体疾病的新兴疗法。
Essays Biochem. 2018 Jul 20;62(3):467-481. doi: 10.1042/EBC20170114.

引用本文的文献

1
Autologous transplantation of mitochondria/rAAV IGF-I platforms in human osteoarthritic articular chondrocytes to treat osteoarthritis.线粒体/重组腺相关病毒胰岛素样生长因子-I平台自体移植治疗人骨关节炎关节软骨细胞中的骨关节炎。
Mol Ther. 2025 Jun 4;33(6):2900-2912. doi: 10.1016/j.ymthe.2024.12.047. Epub 2024 Dec 30.
2
Recent advances and current status of gene therapy for epilepsy.癫痫的基因治疗的最新进展和现状。
World J Pediatr. 2024 Nov;20(11):1115-1137. doi: 10.1007/s12519-024-00843-w. Epub 2024 Oct 12.
3
TBC1D15-regulated mitochondria-lysosome membrane contact exerts neuroprotective effects by alleviating mitochondrial calcium overload in seizure.

本文引用的文献

1
Mitochondrial targeting dendrimer allows efficient and safe gene delivery.线粒体靶向树枝状大分子可实现高效且安全的基因递送。
J Mater Chem B. 2014 May 7;2(17):2546-2553. doi: 10.1039/c3tb21348j. Epub 2013 Dec 23.
2
mitoTev-TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels.mitoTev-TALE:一种单体 DNA 编辑酶,可降低突变线粒体 DNA 水平。
EMBO Mol Med. 2018 Sep;10(9). doi: 10.15252/emmm.201708084.
3
Effect of Nanoparticle Surface Coating on Cell Toxicity and Mitochondria Uptake.纳米颗粒表面涂层对细胞毒性和线粒体摄取的影响。
TBC1D15 调节的线粒体-溶酶体膜接触通过减轻癫痫发作中的线粒体钙超载发挥神经保护作用。
Sci Rep. 2024 Oct 10;14(1):23782. doi: 10.1038/s41598-024-74388-3.
4
Second-Generation Polyamidoamine Dendrimer Conjugated with Oligopeptides Can Enhance Plasmid DNA Delivery In Vitro.第二代聚酰胺-胺树枝状聚合物与寡肽的缀合物可以增强体外质粒 DNA 的传递。
Molecules. 2023 Nov 17;28(22):7644. doi: 10.3390/molecules28227644.
5
Delivery Systems for Mitochondrial Gene Therapy: A Review.线粒体基因治疗的递送系统:综述
Pharmaceutics. 2023 Feb 8;15(2):572. doi: 10.3390/pharmaceutics15020572.
6
Current advances in gene therapy of mitochondrial diseases.线粒体疾病的基因治疗新进展。
J Transl Med. 2022 Dec 5;20(1):562. doi: 10.1186/s12967-022-03685-0.
7
Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective.线粒体疾病的基因治疗:现状与未来展望
Pharmaceutics. 2022 Jun 17;14(6):1287. doi: 10.3390/pharmaceutics14061287.
8
Peptide-Assisted Nucleic Acid Delivery Systems on the Rise.肽辅助核酸递送系统日益兴起。
Int J Mol Sci. 2021 Aug 23;22(16):9092. doi: 10.3390/ijms22169092.
9
Development of Peptide-Based Nanoparticles for Mitochondrial Plasmid DNA Delivery.用于线粒体质粒DNA递送的肽基纳米颗粒的研发。
Polymers (Basel). 2021 Jun 1;13(11):1836. doi: 10.3390/polym13111836.
10
Engineering Genetic Systems for Treating Mitochondrial Diseases.用于治疗线粒体疾病的工程遗传系统。
Pharmaceutics. 2021 May 28;13(6):810. doi: 10.3390/pharmaceutics13060810.
J Biomed Nanotechnol. 2017 Feb;13(2):155-66. doi: 10.1166/jbn.2017.2337.
4
Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.利用 mitoTALENs 靶向消除 MELAS-iPSCs 中的突变线粒体 DNA。
Protein Cell. 2018 Mar;9(3):283-297. doi: 10.1007/s13238-017-0499-y. Epub 2018 Jan 9.
5
Functional nanosome for enhanced mitochondria-targeted gene delivery and expression.功能纳米体增强线粒体靶向基因递呈和表达
Mitochondrion. 2017 Nov;37:27-40. doi: 10.1016/j.mito.2017.06.005. Epub 2017 Jun 29.
6
Validation of the use of an artificial mitochondrial reporter DNA vector containing a Cytomegalovirus promoter for mitochondrial transgene expression.验证含有巨细胞病毒启动子的人工线粒体报告 DNA 载体用于线粒体转基因表达的有效性。
Biomaterials. 2017 Aug;136:56-66. doi: 10.1016/j.biomaterials.2017.05.016. Epub 2017 May 10.
7
Mitochondrial Gene Therapy: Advances in Mitochondrial Gene Cloning, Plasmid Production, and Nanosystems Targeted to Mitochondria.线粒体基因治疗:线粒体基因克隆、质粒生产及靶向线粒体的纳米系统的进展
Mol Pharm. 2017 Mar 6;14(3):626-638. doi: 10.1021/acs.molpharmaceut.6b00823. Epub 2017 Feb 23.
8
Self-Assembled Peptide-Based System for Mitochondrial-Targeted Gene Delivery: Functional and Structural Insights.用于线粒体靶向基因递送的基于自组装肽的系统:功能与结构洞察
Biomacromolecules. 2016 Nov 14;17(11):3547-3557. doi: 10.1021/acs.biomac.6b01056. Epub 2016 Oct 10.
9
Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs.通过使用线粒体锌指核酸酶(mtZFNs)进行迭代或动态剂量控制治疗,近乎完全消除突变型线粒体DNA(mtDNA)。
Nucleic Acids Res. 2016 Sep 19;44(16):7804-16. doi: 10.1093/nar/gkw676. Epub 2016 Jul 27.
10
Validation of Mitochondrial Gene Delivery in Liver and Skeletal Muscle via Hydrodynamic Injection Using an Artificial Mitochondrial Reporter DNA Vector.使用人工线粒体报告基因DNA载体通过流体动力学注射在肝脏和骨骼肌中进行线粒体基因递送的验证
Mol Pharm. 2015 Dec 7;12(12):4311-20. doi: 10.1021/acs.molpharmaceut.5b00511. Epub 2015 Nov 23.